Franklin Resources Inc Evotec Se Transaction History

Franklin Resources Inc

  • $334 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$10.78 - $15.5 $7.92 Million - $11.4 Million
-734,383 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$12.93 - $23.46 $9.92 Million - $18 Million
-767,496 Reduced 51.1%
734,383 $11.1 Million
Q4 2021

Feb 11, 2022
BUY
$22.0 - $25.77 $33 Million - $38.7 Million
1,501,879 New
1,501,879 $35.7 Million

Others Institutions Holding EVO

# of Institutions
25
Shares Held
3.42M
Call Options Held
0
Put Options Held
0
View Full List

About Evotec SE

EVO Quotes by TradingView
  • Ticker EVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 353,904,992
  • Market Cap $1.58B
  • Description
  • Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...
More about EVO
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email